Medica S.p.A. Share Price

Equities

MDC

IT0005460149

Biotechnology & Medical Research

Market Closed - Borsa Italiana 16:44:59 20/05/2024 BST 5-day change 1st Jan Change
26.4 EUR 0.00% Intraday chart for Medica S.p.A. -1.49% +70.32%

Financials

Sales 2024 * 93.11M 101M 7.96B Sales 2025 * 102M 110M 8.67B Capitalization 111M 121M 9.53B
Net income 2024 * 6M 6.51M 513M Net income 2025 * 9M 9.77M 769M EV / Sales 2024 * 1.26 x
Net Debt 2024 * 5.92M 6.42M 505M Net cash position 2025 * 4.79M 5.2M 409M EV / Sales 2025 * 1.05 x
P/E ratio 2024 *
16.3 x
P/E ratio 2025 *
11.9 x
Employees 696
Yield 2024 *
-
Yield 2025 *
-
Free-Float 20.07%
More Fundamentals * Assessed data
Dynamic Chart
1 week-1.49%
1 month+0.76%
3 months+72.55%
6 months+60.00%
Current year+70.32%
More quotes
1 week
26.40
Extreme 26.4
26.60
1 month
26.20
Extreme 26.2
26.80
Current year
14.50
Extreme 14.5
26.80
1 year
14.40
Extreme 14.4
26.80
3 years
14.40
Extreme 14.4
45.80
5 years
14.40
Extreme 14.4
45.80
10 years
14.40
Extreme 14.4
45.80
More quotes
Managers TitleAgeSince
Chief Executive Officer 41 31/12/10
Chairman 75 31/12/89
Chief Administrative Officer 58 31/12/94
Members of the board TitleAgeSince
Director/Board Member 54 13/10/21
Chairman 75 31/12/89
Chief Executive Officer 41 31/12/10
More insiders
Date Price Change Volume
20/05/24 26.4 0.00% 150
17/05/24 26.4 -0.75% 1,850
16/05/24 26.6 0.00% 0
15/05/24 26.6 +0.76% 2,200
14/05/24 26.4 -1.49% 6,300

Real-time Borsa Italiana, May 20, 2024 at 04:44 pm

More quotes
Medica SpA is an Italy-based company primarily engaged in designing, manufacturing and supplying blood purification systems. Through subsidiaries, such as Tecnoideal sel the Company not only offers dialyzers, ultrafilters, HDF online sets, bloodlines, and pediatric dialyzers for dialysis treatment but also provides critical care CRRT equipment, hemofilter, pediatric filters, C02 removal, apheresis equipment, fractionator-cascade filtration, plasma filters, and leukocyte adsorber. It also supplies Cardiosmart, an integrated system for the treatment of patients affected by congestive heart failure; MediSulfone membrane and Purema hemoconcentration. It is engaged in water purification offering systems, including lab-pharma-industrial filtrations, individual water purifiers, and point-of-use filtrations. The Company provides infusion sets, urodynamic systems, palm bladder scanner and gastroenterology systems, among others. It operates globally.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
26.4 EUR
Average target price
31.4 EUR
Spread / Average Target
+18.94%
Consensus

Annual profits - Rate of surprise